376 related articles for article (PubMed ID: 34948292)
21. The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy.
Badawy AA
Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37486805
[TBL] [Abstract][Full Text] [Related]
22. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
23. DSS-induced acute colitis causes dysregulated tryptophan metabolism in brain: an involvement of gut microbiota.
Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Ting-Li ; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
J Nutr Biochem; 2023 May; 115():109282. PubMed ID: 36758839
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease.
Agus A; Planchais J; Sokol H
Cell Host Microbe; 2018 Jun; 23(6):716-724. PubMed ID: 29902437
[TBL] [Abstract][Full Text] [Related]
25. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
26. [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
Mouri A; Hasegawa M; Kunisawa K; Saito K; Nabeshima T
Nihon Yakurigaku Zasshi; 2023 May; 158(3):233-237. PubMed ID: 36990795
[TBL] [Abstract][Full Text] [Related]
27. Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response.
Lai W; Huang Z; Li S; Li XG; Luo D
Int Immunopharmacol; 2023 Apr; 117():109840. PubMed ID: 36827928
[TBL] [Abstract][Full Text] [Related]
28. Association between metabolites in tryptophan-kynurenine pathway and inflammatory bowel disease: a two-sample Mendelian randomization.
Yu F; Du Y; Li C; Zhang H; Lai W; Li S; Ye Z; Fu W; Li S; Li XG; Luo D
Sci Rep; 2024 Jan; 14(1):201. PubMed ID: 38167867
[TBL] [Abstract][Full Text] [Related]
29. An expanding range of targets for kynurenine metabolites of tryptophan.
Stone TW; Stoy N; Darlington LG
Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
[TBL] [Abstract][Full Text] [Related]
30. Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS.
van der Velpen V; Rosenberg N; Maillard V; Teav T; Chatton JY; Gallart-Ayala H; Ivanisevic J
J Neurochem; 2021 Oct; 159(2):378-388. PubMed ID: 33829502
[TBL] [Abstract][Full Text] [Related]
31. Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.
Sofia MA; Ciorba MA; Meckel K; Lim CK; Guillemin GJ; Weber CR; Bissonnette M; Pekow JR
Inflamm Bowel Dis; 2018 Jun; 24(7):1471-1480. PubMed ID: 29796641
[TBL] [Abstract][Full Text] [Related]
32. Secretion of quinolinic acid, an intermediate in the kynurenine pathway, for utilization in NAD+ biosynthesis in the yeast Saccharomyces cerevisiae.
Ohashi K; Kawai S; Murata K
Eukaryot Cell; 2013 May; 12(5):648-53. PubMed ID: 23457190
[TBL] [Abstract][Full Text] [Related]
33.
Gu Z; Pei W; Shen Y; Wang L; Zhu J; Zhang Y; Fan S; Wu Q; Li L; Zhang Z
Food Funct; 2021 Oct; 12(20):10184-10195. PubMed ID: 34532729
[TBL] [Abstract][Full Text] [Related]
34. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR
J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs.
Moffett JR; Blinder KL; Venkateshan CN; Namboodiri MA
Cell Tissue Res; 1998 Sep; 293(3):525-34. PubMed ID: 9716743
[TBL] [Abstract][Full Text] [Related]
36. Kynurenine pathway, NAD
Castro-Portuguez R; Sutphin GL
Exp Gerontol; 2020 Apr; 132():110841. PubMed ID: 31954874
[TBL] [Abstract][Full Text] [Related]
37. Tryptophan-kynurenine metabolic characterization in the gut and brain of depressive-like rats induced by chronic restraint stress.
Li CC; Ye F; Xu CX; Jiang N; Chang Q; Liu XM; Pan RL
J Affect Disord; 2023 May; 328():273-286. PubMed ID: 36746244
[TBL] [Abstract][Full Text] [Related]
38. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
[TBL] [Abstract][Full Text] [Related]
39. Tryptophan degradation as a systems phenomenon in inflammation - an analysis across 13 chronic inflammatory diseases.
Harris DMM; Szymczak S; Schuchardt S; Labrenz J; Tran F; Welz L; Graßhoff H; Zirpel H; Sümbül M; Oumari M; Engelbogen N; Junker R; Conrad C; Thaçi D; Frey N; Franke A; Weidinger S; Hoyer B; Rosenstiel P; Waschina S; Schreiber S; Aden K
EBioMedicine; 2024 Apr; 102():105056. PubMed ID: 38471395
[TBL] [Abstract][Full Text] [Related]
40. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
